How to get acquisition ready – a seller’s guide to merger and acquisition in pharma
pharmaphorum
DECEMBER 28, 2022
In pharma, multi-billion-dollar deals dominate M&A headlines, but most deals are far shorter of this range and generally lie between $10-$500 million. In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. Post-acquisition compliance.
105 
Let's personalize your content